Loading clinical trials...

Alcohol Research in HIV: Relapse Prevention | Clinical Trials | Clareo Health

RECRUITINGNANCT05163301

Alcohol Research in HIV: Relapse Prevention

3-arm type 1 pilot implementation-efficacy trial for people with alcohol use disorders to examine the preliminary effectiveness and feasibility of an adapted 2-session, computerized and person deliver...

Lead sponsor: Johns Hopkins University•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Heidi Hutton, PhD

CONTACT

14104586715 [email protected]

Related studies

RECRUITINGPhase 1

Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)

NCT07223983 · Alcohol Use Disorder, Weight Loss, and more

RECRUITINGNA

The Effects of Chiropractic Care on Inflammation and Quality of Life in People Living With HIV

NCT07466836 · Human Immunodeficiency Virus (HIV)

RECRUITINGNA

Stress and Pain in People Living With HIV

NCT06784908 · HIV, Depression, and more

RECRUITINGPhase 2

Evaluation of Long-Acting Lenacapavir for the Treatment of HIV-1 in Treatment-experienced Adolescents and Children

NCT06749054 · HIV-1-infection

RECRUITING

Thinking and Memory Problems in People With HIV

NCT01875588 · HIV Positive

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: February 18, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment150

Start dateMar 2023

Last updatedFeb 18, 2026

Condition

HIV Alcohol Use Disorder

Locations shown

Johns Hopkins School of Medicine

Baltimore, Maryland

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 18, 2026Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions